Canasa is a Rectal Suppository in the Human Prescription Drug category. It is labeled and distributed by Mckesson Rxpak Inc. The primary component is Mesalamine.
Product ID | 65084-474_f22429d1-5a9e-4286-a856-8104e188e35e |
NDC | 65084-474 |
Product Type | Human Prescription Drug |
Proprietary Name | Canasa |
Generic Name | Mesalamine |
Dosage Form | Suppository |
Route of Administration | RECTAL |
Marketing Start Date | 2001-01-05 |
Marketing Category | NDA / NDA |
Application Number | NDA021252 |
Labeler Name | Mckesson Rxpak Inc |
Substance Name | MESALAMINE |
Active Ingredient Strength | 1000 mg/1 |
Pharm Classes | Aminosalicylate [EPC],Aminosalicylic Acids [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2016-01-20 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021252 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2016-01-20 |
Marketing End Date | 2019-09-01 |
Ingredient | Strength |
---|---|
MESALAMINE | 1000 mg/1 |
SPL SET ID: | 75fb1efa-d513-4203-8962-6508a24ef3eb |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
58914-501 | Canasa | Canasa |
65084-474 | Canasa | Canasa |
0023-5901 | Asacol HD | mesalamine |
0430-0783 | ASACOL HD | mesalamine |
0023-5853 | Delzicol | mesalamine |
0179-0142 | Lialda | mesalamine |
0093-5907 | Mesalamine | Mesalamine |
0093-9224 | mesalamine | mesalamine |
0378-1375 | Mesalamine | mesalamine |
0378-9230 | Mesalamine | mesalamine |
0472-1915 | Mesalamine | Mesalamine |
0037-0066 | Rowasa | mesalamine |
0037-0022 | sfRowasa | mesalamine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CANASA 76124724 2595613 Live/Registered |
APTALIS PHARMA US, INC. 2000-09-08 |